OKLAHOMA CITY, Sept. 10, 2008 (GLOBE NEWSWIRE) -- Federman & Sherwood today announced that it has launched an investigation of Spectranetics Corp. (Nasdaq:SPNC) for possible misrepresentations or material omissions made by officers and directors with respect to the import and marketing of certain medical products manufactured outside the United States. On September 4, 2008, the Company issued press releases disclosing that it was under federal investigation with respect to the foregoing issues, and that search warrants had been served on the Company by government agencies. When this announcement was made, Spectranetics' stock fell sharply, causing NASDAQ to temporarily halt trading of the Company's stock.
If you have information relevant to this investigation, or you believe you were harmed by this information, you are urged to contact William B. Federman at Federman & Sherwood, WBF@federmanlaw.com or (405) 692-2136. Federman & Sherwood has experience and expertise in actions involving financial and securities fraud. Our firm has represented investors throughout the nation and concentrates its practice in securities class actions and shareholder derivative litigation.